Ovation Science

Ovation Science ROE

The Return on Equity (ROE) of Ovation Science (OVAT.CN) as of Oct 30, 2026 is 43.26 %. In the previous year, Return on Equity (ROE) was 41.84 % — a change of 3.41% (higher).

ROE

43.26 %

YoY

3.41%

Last updated:

In 2025, Ovation Science's return on equity (ROE) was 43.26 %, a 3.41% increase from the 41.84 % ROE in the previous year.

The Ovation Science ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-23.22 CAD
Jan 1, 2019
-56.57 CAD
Jan 1, 2020
-38.12 CAD
Jan 1, 2021
-338.99 CAD
Jan 1, 2022
957.24 CAD
Jan 1, 2023
124.70 CAD
Jan 1, 2024
41.84 CAD
Jan 1, 2025
43.26 CAD
The Ovation Science ROE history
YEARROEYoY
43.26 %+3.41%
41.84 %-66.45%
124.70 %-86.97%
957.24 %-382.38%
-338.99 %+789.29%
-38.12 %-32.62%
-56.57 %+143.64%
-23.22 %-11.11%
-26.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ovation Science Stock analysis

What does Ovation Science do? Ovation Science, Inc. generates revenue through the development and sale of topical and transdermal skin products utilizing its patented Invisicare delivery technology. The company offers products under the Ovation brand, ARLO CBD Beauty, and InVibe MD, featuring formulations with hemp seed oil, CBD, THC, and cannabinoid derivatives. These products are distributed through direct sales and licensing agreements, targeting consumers seeking science-based skincare and wellness solutions. The firm leverages its Invisicare technology to create creams and lotions that deliver cannabinoids and hemp seed oil effectively for topical and transdermal use. The company's product portfolio includes ARLO CBD Beauty for skincare and InVibe MD for wellness, both powered by the Invisicare delivery system. Ovation Science licenses its technology and products to third parties while also selling directly under its own brands. The primary market segments are consumers interested in cannabinoid-based skincare and wellness products, with a focus on the efficacy and science-backed nature of their formulations. All products are manufactured and distributed under the company's brand labels, emphasizing the patented delivery system as a key differentiator. Ovation Science, Inc. monetizes its patented Invisicare technology by developing and distributing products containing cannabinoids, hemp seed oil, and synthetic cannabis derivatives. The company's revenue streams come from both direct sales of Ovation-branded products and licensing agreements for its technology and formulations. The firm's focus on topical and transdermal delivery ensures that its products are positioned within the growing market for cannabinoid-infused skincare and wellness solutions, targeting customers who prioritize the science and technology behind their skincare products. Ovation Science is one of the most popular companies on Eulerpool.

ROE Details

Decoding Ovation Science's Return on Equity (ROE)

Ovation Science's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Ovation Science's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Ovation Science's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Ovation Science’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Ovation Science stock

Return on Equity (ROE) of Ovation Science is 43.26 % in 2025.

Return on Equity (ROE) of Ovation Science changed from 41.84 % to 43.26 %, representing a 3.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Ovation Science since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Ovation Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ovation Science

All Key Metrics — Ovation Science